Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
SCRI serves as Singapore’s national academic clinical research organization. It provides infrastructure and expertise for the design and execution of high-quality multi-site clinical trials across key therapeutic areas. It coordinates national trial strategies to enhance patient outcomes and strengthen Singapore’s position as a regional hub for advanced clinical research. No proprietary drug development or direct trial results are reported by SCRI itself; it enables results for partner institutions
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Singapore Clinical Research Institute.